S-ClassAbout S-Class
U
UTHRAI Stock Diagnostic Report
United Therapeutics jumps 13% on court ruling
United Therapeutics' stock surged 13% on a favorable court ruling.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICE$541.89Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support468.97
Near-Term Resistance517.75
02
FUNDAMENTALS
Financial & Fundamental Analysis
Winning the patent lawsuit protects the exclusive rights of its core business, securing stability in mid- to long-term performance.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The current price is trading above the 20-day resistance line ($517.75), and a dip-buying strategy based on the support line ($468.97) remains valid.
Support468.97
Resistance517.75
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The stock price surged 13% after a favorable court ruling in a patent infringement lawsuit, resolving competitor risk.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-09-30)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.